Page last updated at 20:35 GMT, Monday, 24 August 2009 21:35 UK

Procter in $3.1bn drug unit sale

Strips of drugs
Warner said the deal would turn it into a global drugs giant

Irish drugmaker Warner Chilcott is buying the pharmaceutical business of Procter & Gamble for $3.1bn (£1.9bn).

The move will see Warner more than triple its annual turnover, and the firm's US listed shares jumped 26% following the announcement.

US consumer products giant Procter said it was ending its involvement in the production of prescription drugs.

Procter makes everything from Gillette razors to Pringles crisps, Duracell batteries, and Fairy washing liquid.

"The acquisition transforms Warner Chilcott into a global pharmaceutical company," said the Irish company.

Warner is financing the deal through debt, and said the majority of the 2,300 employees in Procter's pharmaceuticals unit would simply transfer across.

Analysts say that Procter said decided to exit the business because of the growth in competition from generic drugmakers.

Procter's branded drugs, such as osteoporosis treatment Actonel, have annual sales of $2.3bn.



Print Sponsor


RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites


FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

BBC iD

Sign in

BBC navigation

Copyright © 2018 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific